aluates Reports

$ 0.0

Automative

Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-35X15123

Global Treatment of Chemotherapy Induced Nausea in Cancer Patients Market Insights Forecast to 2029

BUY CHAPTERS

Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Research Report 2025

Code: QYRE-Auto-35X15123

Report

February 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Heron Therapeutics

Merck

Eisai Co Ltd

Mundipharma

Qilu Pharma

TEVA

Novartis

Roche

Mylan NV

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size

The global market for Treatment of Chemotherapy-Induced Nausea in Cancer Patients was valued at US$ 2310 million in the year 2024 and is projected to reach a revised size of US$ 2061 million by 2031, growing at a CAGR of -1.6% during the forecast period.

Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.

The chemotherapy-induced nausea and vomiting (CINV) treatment market is driven by the increasing prevalence of cancer and the growing adoption of effective antiemetic therapies. Chemotherapy often causes nausea and vomiting, adversely affecting the quality of life of cancer patients. The rise in cancer incidence and the need for better supportive care contribute to market growth as healthcare providers and patients seek reliable CINV treatments to manage these distressing side effects. Moreover, advancements in antiemetic drug development and the introduction of combination therapies have improved treatment efficacy and patient outcomes. However, the market also faces challenges, including the individual variability in CINV response and the need for tailored treatment approaches. Additionally, addressing the cost of antiemetic drugs and ensuring accessibility to patients can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and patient-centric CINV treatments, collaborate with oncologists to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated antiemetic therapies for cancer patients undergoing chemotherapy.

This report aims to provide a comprehensive presentation of the global market for Treatment of Chemotherapy-Induced Nausea in Cancer Patients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment of Chemotherapy-Induced Nausea in Cancer Patients.

The Treatment of Chemotherapy-Induced Nausea in Cancer Patients market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Treatment of Chemotherapy-Induced Nausea in Cancer Patients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Treatment of Chemotherapy-Induced Nausea in Cancer Patients companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Report

Report Metric	Details
Report Name	Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market
Accounted market size in year	US$ 2310 million
Forecasted market size in 2031	US$ 2061 million
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	5-HT3 Inhibitors NK1 Inhibitors Other
Segment by Application	Acute CINV Delayed CINV Breakthrough CINV Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Treatment of Chemotherapy-Induced Nausea in Cancer Patients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market size in 2031?

Ans: The Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market size in 2031 will be US$ 2061 million.

Who are the main players in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market report?

Ans: The main players in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market are Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma

What are the Application segmentation covered in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market report?

Ans: The Applications covered in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market report are Acute CINV, Delayed CINV, Breakthrough CINV, Others

What are the Type segmentation covered in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market report?

Ans: The Types covered in the Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market report are 5-HT3 Inhibitors, NK1 Inhibitors, Other

Recommended Reports

Cancer Therapy Drugs

Targeted Cancer Treatments

Innovative Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 5-HT3 Inhibitors

1.2.3 NK1 Inhibitors

1.2.4 Other

1.3 Market by Application

1.3.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Acute CINV

1.3.3 Delayed CINV

1.3.4 Breakthrough CINV

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Perspective (2020-2031)

2.2 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Growth Trends by Region

2.2.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Historic Market Size by Region (2020-2025)

2.2.3 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Region (2026-2031)

2.3 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Dynamics

2.3.1 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Industry Trends

2.3.2 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Drivers

2.3.3 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Challenges

2.3.4 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Treatment of Chemotherapy-Induced Nausea in Cancer Patients Players by Revenue

3.1.1 Global Top Treatment of Chemotherapy-Induced Nausea in Cancer Patients Players by Revenue (2020-2025)

3.1.2 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue Market Share by Players (2020-2025)

3.2 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue

3.4 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Concentration Ratio

3.4.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue in 2024

3.5 Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients Head office and Area Served

3.6 Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients, Product and Application

3.7 Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Breakdown Data by Type

4.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Historic Market Size by Type (2020-2025)

4.2 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Type (2026-2031)

5 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Breakdown Data by Application

5.1 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Historic Market Size by Application (2020-2025)

5.2 Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (2020-2031)

6.2 North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025)

6.4 North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (2020-2031)

7.2 Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025)

7.4 Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (2020-2031)

8.2 Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (2020-2025)

8.4 Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (2020-2031)

9.2 Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025)

9.4 Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (2020-2031)

10.2 Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025)

10.4 Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Heron Therapeutics

11.1.1 Heron Therapeutics Company Details

11.1.2 Heron Therapeutics Business Overview

11.1.3 Heron Therapeutics Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.1.4 Heron Therapeutics Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.1.5 Heron Therapeutics Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.2.4 Merck Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Eisai

11.3.1 Eisai Company Details

11.3.2 Eisai Business Overview

11.3.3 Eisai Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.3.4 Eisai Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.3.5 Eisai Recent Development

11.4 Mundipharma

11.4.1 Mundipharma Company Details

11.4.2 Mundipharma Business Overview

11.4.3 Mundipharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.4.4 Mundipharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.4.5 Mundipharma Recent Development

11.5 Qilu Pharma

11.5.1 Qilu Pharma Company Details

11.5.2 Qilu Pharma Business Overview

11.5.3 Qilu Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.5.4 Qilu Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.5.5 Qilu Pharma Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.6.4 Teva Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.6.5 Teva Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.7.4 Novartis Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Roche

11.8.1 Roche Company Details

11.8.2 Roche Business Overview

11.8.3 Roche Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.8.4 Roche Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.8.5 Roche Recent Development

11.9 Mylan

11.9.1 Mylan Company Details

11.9.2 Mylan Business Overview

11.9.3 Mylan Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.9.4 Mylan Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.9.5 Mylan Recent Development

11.10 Baxter

11.10.1 Baxter Company Details

11.10.2 Baxter Business Overview

11.10.3 Baxter Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.10.4 Baxter Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.10.5 Baxter Recent Development

11.11 GSK

11.11.1 GSK Company Details

11.11.2 GSK Business Overview

11.11.3 GSK Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.11.4 GSK Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.11.5 GSK Recent Development

11.12 Helsinn

11.12.1 Helsinn Company Details

11.12.2 Helsinn Business Overview

11.12.3 Helsinn Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.12.4 Helsinn Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.12.5 Helsinn Recent Development

11.13 Southwest Pharma

11.13.1 Southwest Pharma Company Details

11.13.2 Southwest Pharma Business Overview

11.13.3 Southwest Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.13.4 Southwest Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.13.5 Southwest Pharma Recent Development

11.14 Haisco

11.14.1 Haisco Company Details

11.14.2 Haisco Business Overview

11.14.3 Haisco Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.14.4 Haisco Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.14.5 Haisco Recent Development

11.15 Sun Pharma

11.15.1 Sun Pharma Company Details

11.15.2 Sun Pharma Business Overview

11.15.3 Sun Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Introduction

11.15.4 Sun Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

11.15.5 Sun Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Heron Therapeutics

Merck

Eisai Co Ltd

Mundipharma

Qilu Pharma

TEVA

Novartis

Roche

Mylan NV

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

List of Tables

Table 1. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 5-HT3 Inhibitors

Table 3. Key Players of NK1 Inhibitors

Table 4. Key Players of Other

Table 5. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Region (2020-2025)

Table 9. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Region (2026-2031)

Table 11. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Trends

Table 12. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Drivers

Table 13. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Challenges

Table 14. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Restraints

Table 15. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Players (2020-2025)

Table 17. Global Top Treatment of Chemotherapy-Induced Nausea in Cancer Patients Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients as of 2024)

Table 18. Ranking of Global Top Treatment of Chemotherapy-Induced Nausea in Cancer Patients Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients, Headquarters and Area Served

Table 21. Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients, Product and Application

Table 22. Global Key Players of Treatment of Chemotherapy-Induced Nausea in Cancer Patients, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue Market Share by Type (2020-2025)

Table 26. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue Market Share by Type (2026-2031)

Table 28. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue Market Share by Application (2020-2025)

Table 30. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue Market Share by Application (2026-2031)

Table 32. North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Country (2026-2031) & (US$ Million)

Table 47. Heron Therapeutics Company Details

Table 48. Heron Therapeutics Business Overview

Table 49. Heron Therapeutics Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 50. Heron Therapeutics Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 51. Heron Therapeutics Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 55. Merck Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Eisai Company Details

Table 58. Eisai Business Overview

Table 59. Eisai Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 60. Eisai Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 61. Eisai Recent Development

Table 62. Mundipharma Company Details

Table 63. Mundipharma Business Overview

Table 64. Mundipharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 65. Mundipharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 66. Mundipharma Recent Development

Table 67. Qilu Pharma Company Details

Table 68. Qilu Pharma Business Overview

Table 69. Qilu Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 70. Qilu Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 71. Qilu Pharma Recent Development

Table 72. Teva Company Details

Table 73. Teva Business Overview

Table 74. Teva Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 75. Teva Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 76. Teva Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 80. Novartis Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. Roche Company Details

Table 83. Roche Business Overview

Table 84. Roche Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 85. Roche Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 86. Roche Recent Development

Table 87. Mylan Company Details

Table 88. Mylan Business Overview

Table 89. Mylan Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 90. Mylan Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 91. Mylan Recent Development

Table 92. Baxter Company Details

Table 93. Baxter Business Overview

Table 94. Baxter Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 95. Baxter Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 96. Baxter Recent Development

Table 97. GSK Company Details

Table 98. GSK Business Overview

Table 99. GSK Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 100. GSK Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 101. GSK Recent Development

Table 102. Helsinn Company Details

Table 103. Helsinn Business Overview

Table 104. Helsinn Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 105. Helsinn Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 106. Helsinn Recent Development

Table 107. Southwest Pharma Company Details

Table 108. Southwest Pharma Business Overview

Table 109. Southwest Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 110. Southwest Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 111. Southwest Pharma Recent Development

Table 112. Haisco Company Details

Table 113. Haisco Business Overview

Table 114. Haisco Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 115. Haisco Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 116. Haisco Recent Development

Table 117. Sun Pharma Company Details

Table 118. Sun Pharma Business Overview

Table 119. Sun Pharma Treatment of Chemotherapy-Induced Nausea in Cancer Patients Product

Table 120. Sun Pharma Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025) & (US$ Million)

Table 121. Sun Pharma Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Picture

Figure 2. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Type: 2024 VS 2031

Figure 4. 5-HT3 Inhibitors Features

Figure 5. NK1 Inhibitors Features

Figure 6. Other Features

Figure 7. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Application: 2024 VS 2031

Figure 9. Acute CINV Case Studies

Figure 10. Delayed CINV Case Studies

Figure 11. Breakthrough CINV Case Studies

Figure 12. Others Case Studies

Figure 13. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Report Years Considered

Figure 14. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Region: 2024 VS 2031

Figure 17. Global Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Players in 2024

Figure 18. Global Top Treatment of Chemotherapy-Induced Nausea in Cancer Patients Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment of Chemotherapy-Induced Nausea in Cancer Patients as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Treatment of Chemotherapy-Induced Nausea in Cancer Patients Revenue in 2024

Figure 20. North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Country (2020-2031)

Figure 22. United States Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Country (2020-2031)

Figure 26. Germany Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Region (2020-2031)

Figure 34. China Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Country (2020-2031)

Figure 42. Mexico Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Share by Country (2020-2031)

Figure 46. Turkey Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Treatment of Chemotherapy-Induced Nausea in Cancer Patients Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Heron Therapeutics Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 51. Eisai Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 52. Mundipharma Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 53. Qilu Pharma Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 54. Teva Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 56. Roche Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 57. Mylan Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 58. Baxter Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 59. GSK Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 60. Helsinn Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 61. Southwest Pharma Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 62. Haisco Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 63. Sun Pharma Revenue Growth Rate in Treatment of Chemotherapy-Induced Nausea in Cancer Patients Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Insights Forecast to 2030

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030

Chemotherapy induced Nausea and Vomiting Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Induced Neutropenia CIN Drug Market Research Report 2025

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights Forecast to 2030

Global Chemotherapy Induced Oral Mucositis Treatment Market Research Report 2024

Global Chemotherapy Induced Myelosuppression Treatments Market Research Report 2024

Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Supportive Care Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Postoperative Nausea and Vomiting Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ondansetron Hydrochloride Injection Market Research Report 2024

Global Electronic Antiemetic Device Market Research Report 2024

Global Ramosetron Market Research Report 2024

Global Chemotherapy Drug Market Insights Forecast to 2030

Global Nausea And Vomiting Treatment Market Insights Forecast to 2030

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Medical Electronic Antiemetic Device Market Research Report 2024

Global Chemotherapy Induced Anemia Drug Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions